John Lund
Overview
Explore the profile of John Lund including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
667
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quinlan J, Maganaris C, Franchi M, Smith K, Atherton P, Szewczyk N, et al.
J Gerontol A Biol Sci Med Sci
. 2017 Oct;
73(4):539-545.
PMID: 28977366
Background: The ability to rapidly generate and transfer muscle force is essential for effective corrective movements in order to prevent a fall. The aim of this study was to establish...
2.
Mitchell W, Williams J, Atherton P, Larvin M, Lund J, Narici M
Front Physiol
. 2012 Aug;
3:260.
PMID: 22934016
Changing demographics make it ever more important to understand the modifiable risk factors for disability and loss of independence with advancing age. For more than two decades there has been...
3.
Stewart R, Thom G, Levens M, Guler-Gane G, Holgate R, Rudd P, et al.
Protein Eng Des Sel
. 2011 May;
24(9):671-8.
PMID: 21596686
Ribosome display was applied to the Fc region of human immunoglobulin G (IgG1) to select for improved binding to human FcγRIIIa, the receptor expressed on human natural killer cells that...
4.
Lund J, Parviz B
Methods Mol Biol
. 2009 Sep;
578:113-22.
PMID: 19768589
We provide an overview of the current state of research towards DNA sequencing using nanopore and scanning probe techniques. Additionally, we provide methods for the creation of two key experimental...
5.
Bonetto S, Spadola L, Buchanan A, Jermutus L, Lund J
FASEB J
. 2008 Oct;
23(2):575-85.
PMID: 18957574
Identification of short, structured peptides able to mimic potently protein-protein interfaces remains a challenge in drug discovery. We report here the use of a naive cyclic peptide phage display library...
6.
Ryan D, Rahimi M, Lund J, Mehta R, Parviz B
Trends Biotechnol
. 2007 Jul;
25(9):385-9.
PMID: 17658190
This article reports on the state-of-the-art technologies that sequence DNA using miniaturized devices. The article considers the miniaturization of existing technologies for sequencing DNA and the opportunities for cost reduction...
7.
Lund J, Mehta R, Parviz B
Nanomedicine
. 2007 Feb;
2(4):230-8.
PMID: 17292148
We present the fabrication and characterization of a nano-scale sensor made of amorphous silicon for the label-free, electronic detection of three classes of biologically important molecules: ions, oligonucleotides, and proteins....
8.
Enever C, Tomlinson I, Lund J, Levens M, Holliger P
J Mol Biol
. 2005 Mar;
347(1):107-20.
PMID: 15733921
Protein L (PpL) is a B-cell superantigen from Peptostreptococcus magnus known to bind to mammalian Vkappa light chains. PpL from P.magnus strain 312 comprises five homologous immunoglobulin (Ig) binding domains....
9.
Watt G, Lund J, Levens M, Kumar Kolli V, Jefferis R, Boons G
Chem Biol
. 2003 Oct;
10(9):807-14.
PMID: 14522051
A range of well-defined IgG glycoforms was prepared by employing a combination of synthetic carbohydrate chemistry and genetic engineering. The key aspect of this methodology is the coupling of thioaldoses...
10.
Jefferis R, Lund J
Immunol Lett
. 2002 May;
82(1-2):57-65.
PMID: 12008035
Recombinant monoclonal antibodies have entered the clinic as effective in vivo therapeutic. A majority of the therapeutics antibodies employed are intact IgG molecules. IgG-antibody/antigen complexes can activate a wide range...